The science of bioinformatics has developed in the wake of methods to determine the sequences of the informational macromolecules-DNAs, RNAs and proteins. But in a wider sense, the biological world depends in its every process on the transmission of information, and hence bioinformatics is the fundamental core of biology. We here give a consideration of some of the key problems of bioinformatics in the coming decade, and perhaps longer.
INTRODUCTION
Biology may be viewed as the study of transmission of information: from mother cell to daughter cell, from one cell or tissue type to another, from one generation to the next, and from one species to another. This informational viewpoint is termed bioinformatics.
The beginnings of bioinformatics may be traced to the discovery by Sanger & co-workers that the protein insulin has a definite amino acid sequence. Sanger (1952) noted that, 'It has frequently been suggested that proteins may not be pure chemical entities but may consist of mixtures of closely related substances with no absolute unique structure. The chemical results so far obtained suggest that this is not the case and that a protein is really a single chemical substance, each molecule of one protein being identical with every other molecule of the same pure protein. Thus, it was possible to assign a unique structure to the. chains of insulin. Each position in the chain was occupied by only one amino acid and there was no evidence that any of them could be occupied by a different residue.. These results would imply an absolute specificity for the mechanisms responsible for protein synthesis. (Sanger 1952) '. So, he had concluded that proteins are perfectly ordered, and that there must be a mechanism responsible for this order. It was not a huge step from this conclusion to the idea of a genetic code.
Soon after, Sanger & his co-workers (Ryle et al. 1955) found that the sequences of insulin from sheep and pig differ from that of beef insulin in positions 8-10 of the A-chain, although the B-chains are identical. This set of differences in sequence found among the insulin of different species was the discovery of homologues. The display of these differences was essentially the earliest alignment of a sequence family.
In any case, with the advent of whole genome sequencing, and other tools that offer genome-wide information, bioinformatics has grown into the scientific field of management and analysis of biological information.
In this paper, we make no attempt to catalogue the past achievements of bioinformatics or to classify its subfields. This is done effectively in the other papers in this issue. Rather we present several challenges for exploration in the field of bioinformatics in the future. A few of these questions are specific. Others are general. Our goal is to provoke, not to inform. The questions with a few comments follow.
2. GENOME SEQUENCES AND THEIR EXPRESSION RNA. New forms of RNA with new structures and new functions continue to be discovered. One example of newly discovered RNAs is riboswitch RNAs, containing aptamer domains, typically 70-170 nucleotides in length. They tend to be located within the 5 0 -untranslated regions of the main coding region of a particular mRNA, and are capable of sensing metabolites, and then regulating gene expression (Winkler & Breaker 2003; Tucker & Breaker 2005 
EXTENSIONS OF THE GENETIC CODE: COVALENT MODIFICATIONS, THE ENVIRONMENT AND EPIGENETICS
The genetic code specifies not only the sequences of proteins, but also a vast range of variation of these proteins through covalent modifications. These modifications include both cutting by proteolysis and splicing through several mechanisms. They also include dozens of sidechain reactions catalyzed by enzymes themselves specified by the genetic code. It has been estimated that at least 10% of the proteins encoded by the human genome code for enzymes that modify proteins (Marcotte 2001 determined by a single genetic locus of the host cell, or by many loci?
GENOMIC MEDICINE
A bioinformatics frontier of vast importance is genomic medicine: the application of bioinformatics to diagnosis, prognosis and therapy. A very general question is: (xv) What types of genomic and proteomic molecular profiles from a patient are necessary to extract useful classifiers? The classifiers sought are those that distinguish patients who will respond well to a drug to those who will not, and which drugs are likely to have adverse side effects in given patients.
SPECIES AND EVOLUTION
Among the most intensely studied questions to which bioinformatics can contribute are those that relate to the evolution of life on earth. Much work is presently directed towards constructing an accurate tree of life, and towards understanding the molecular events that underlie evolution. Some specific questions in this area are: (xvi) Can a species be defined at the genomic (molecular) level? Is the barrier to interbreeding of species defined by a small number of genetic loci, or by many distributed changes throughout the genome? Does speciation come about through changes at a small number of loci, or many loci? How do species sub-types coevolve under differing selection pressures? (xvii) What was the origin of the great profusion of protein sequences? Why are there so many apparent singlet ('ORFan') sequence families?
THE CHALLENGE TO BIOINFORMATICS IN THE TWENTY-FIRST CENTURY
The questions above are a small sample of those that face our nascent field as we enter a new century. We expect that genome-wide information will continue to expand in types, and to grow in abundance. As DNA sequences for individuals become available, along with RNA and protein profiles, medical informatics will blossom as a field, and undoubtedly divide into as many subfields as there are medical specialties. Along with medicine, we expect that other sciences will become increasingly involved, such as ecology and public health, among others.
